Mukherjee, Sarbajit http://orcid.org/0000-0003-2153-3896
Fountzilas, Christos
Boland, Patrick M.
Gosain, Rohit
Attwood, Kristopher
Tan, Wei
Khushalani, Nikhil
Iyer, Renuka
Funding for this research was provided by:
Pfizer
Article History
First Online: 4 December 2019
Compliance with Ethical Standards
:
: This study was support by a research grant from Pfizer, Inc. This work was partially supported by National Cancer Institute (NCI) Grant P30CA016056 involving the use of Roswell Park’s Bioanalytics, Metabolomics and Pharmacokinetics (BMPK).
: Sarbajit Mukherjee: Research funding from National Comprehensive Cancer Network (NCCN) and North American Neuroendocrine Tumor Society (NANETS). Christos Fountzilas: Consultation for AstraZeneca—fees paid to the institute. Patrick M Boland: Research funding from Merck, Boehringer Ingelheim, Theradiagnostics—consulting fees Merrimack, Boston Biomedical. Nikhil Khushalani: Advisory Board: Array, BMS, HUYA, Merck, EMD Serono, Regeneron, Immunocore, Genentech Honorarium: Sanofi Data Safety Monitoring Board: Astra Zeneca Research Grants (to institute): BMS, Merck, Celgene, Regeneron, GSK, HUYA, Amgen, Novartis Stock Ownership: Bellicum, Mazor Robotics, Amarin, TransEnterix. Rohit Gosain, Kristopher Atwood, Wei Tan, Renuka Iyer: No potential conflicts of interest that might be relevant to the content of this article.